Carisma Therapeutics Inc Quick Ratio (CARM) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Carisma Therapeutics Inc   (NASDAQ: CARM)

Carisma Therapeutics Inc 's Quick Ratio

CARM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Carisma Therapeutics Inc 's Cash & cash equivalent grew by 38.92 % in the Q3 2025 sequentially, while Current Liabilities decreased, this led to improvement in Carisma Therapeutics Inc 's Quick Ratio to 0.41, Quick Ratio remained below Carisma Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry 324 other companies have achieved higher Quick Ratio than Carisma Therapeutics Inc in third quarter 2025. While Quick Ratio total ranking in the third quarter 2025 has deteriorated compared to the prior quarter from 1754 to 1828.

Explain Quick Ratio?
How much Cash & cash equivalents CARM´s has?
What are CARM´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CARM Quick Ratio (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3
Y / Y Current Liabilities Change -35.48 % -42.69 % -20.5 % 0.92 % -18.48 %
Y / Y Cash & cash equivalent Change -89.67 % -95.05 % -86.3 % -76.92 % -71.44 %
Quick Ratio MRQ 0.41 0.22 0.74 1.12 2.55
CARM's Total Ranking # 1828 # 1754 # 1855 # 887 # 895
Seq. Current Liabilities Change -23.89 % -14.33 % -34.93 % 52.06 % -32.39 %
Seq. Cash & cash equivalent Change 38.92 % -74.17 % -56.78 % -33.38 % -33.4 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 325
Healthcare Sector # 615
Overall Market # 1828


Quick Ratio Statistics
High Average Low
20.04 6.06 0.22
(Mar 31 2022)   (Jun 30 2025)




Financial Statements
Carisma Therapeutics Inc 's Current Liabilities $ 7 Millions Visit CARM's Balance sheet
Carisma Therapeutics Inc 's Cash & cash equivalent $ 3 Millions Visit CARM's Balance sheet
Source of CARM's Sales Visit CARM's Sales by Geography


Cumulative Carisma Therapeutics Inc 's Quick Ratio

CARM's Quick Ratio for the trailling 12 Months

CARM Quick Ratio

 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth -23.47 % -20.15 % -12.17 % -18.94 % -13.86 %
Y / Y Cash & cash equivalent TTM Growth -84.89 % -79.7 % -73.1 % -66.88 % -49.93 %
Quick Ratio TTM 0.72 1.19 1.76 2.56 3.65
Total Ranking TTM # 3218 # 1808 # 3035 # 3230 # 3182
Seq. Current Liabilities TTM Growth -8.14 % -12.66 % -4.87 % 0.27 % -4.15 %
Seq. Cash & cash equivalent TTM Growth -44.2 % -41.3 % -34.43 % -29.65 % -25.04 %

Quick ratio ranking by company, industry and sector >> Back to CARM Financial Strength Comparisons >> Go to Compare CARM Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CARM's Current Liabilities to $6.81 millions, cumulative Quick Ratio to 0.72 below the CARM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 416 other companies have achieved higher Quick Ratio than Carisma Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 1808 to 3218.

Explain Quick Ratio?
How much Cash & cash equivalents CARM´s has?
What are CARM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 417
Healthcare Sector # 865
Within the Market # 3218


trailing twelve months Quick Ratio Statistics
High Average Low
10.55 5.69 0.72
(Mar 31 2022)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Nervgen Pharma Corp   1.12 $ 16.905  Millions$ 15.115  Millions
Cypherpunk Technologies Inc   1.12 $ 9.686  Millions$ 8.666  Millions
Maia Biotechnology Inc   1.09 $ 10.892  Millions$ 9.994  Millions
Dar Bioscience Inc   1.09 $ 23.075  Millions$ 21.216  Millions
Shuttle Pharmaceuticals Holdings Inc   1.07 $ 2.095  Millions$ 1.965  Millions
Opus Genetics Inc   1.06 $ 30.815  Millions$ 29.087  Millions
Cingulate Inc   1.04 $ 6.119  Millions$ 5.882  Millions
Supernus Pharmaceuticals inc   1.04 $ 151.371  Millions$ 146.170  Millions
Evotec Se  1.01 $ 360.490  Millions$ 356.680  Millions
Abbott Laboratories  1.01 $ 7,733.000  Millions$ 7,672.000  Millions
Integrated Biopharma Inc  0.99 $ 4.732  Millions$ 4.764  Millions
Beyondspring Inc   0.99 $ 12.483  Millions$ 12.579  Millions
Kamada Ltd   0.99 $ 71.997  Millions$ 72.931  Millions
Serina Therapeutics Inc   0.98 $ 8.620  Millions$ 8.789  Millions
Keenova Therapeutics Plc  0.98 $ 1,047.900  Millions$ 1,071.100  Millions
Ani Pharmaceuticals Inc  0.97 $ 262.610  Millions$ 270.555  Millions
Bioxcel Therapeutics Inc   0.96 $ 36.176  Millions$ 37.804  Millions
Clene Inc   0.95 $ 7.925  Millions$ 8.306  Millions
Nurix Therapeutics Inc   0.95 $ 78.438  Millions$ 82.350  Millions
Nanoviricides inc   0.95 $ 1.126  Millions$ 1.182  Millions
Evoke Pharma Inc   0.95 $ 11.576  Millions$ 12.241  Millions
Quoin Pharmaceuticals Ltd   0.94 $ 5.431  Millions$ 5.765  Millions
Nanobiotix S a   0.92 $ 59.080  Millions$ 64.408  Millions
Geron Corporation  0.91 $ 79.993  Millions$ 87.712  Millions
Axsome Therapeutics Inc   0.90 $ 325.272  Millions$ 360.290  Millions
Zomedica Corp   0.89 $ 7.496  Millions$ 8.432  Millions
Prestige Consumer Healthcare Inc   0.88 $ 119.106  Millions$ 134.604  Millions
Eton Pharmaceuticals Inc   0.84 $ 37.121  Millions$ 44.183  Millions
Tg Therapeutics Inc   0.84 $ 131.582  Millions$ 156.810  Millions
Medicus Pharma Ltd   0.81 $ 8.662  Millions$ 10.658  Millions

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.